Marketing research firm IMS Health has announced the election of Bradley Sheares to its board of directors. Shears was most recently CEO of Reliant Pharmaceuticals. Prior to Reliant, Sheares was president of Merck's US human health division.
ANI Pharmaceuticals, a specialty generic pharmaceuticals manufacturer, has announced the appointment of Arthur Przbyl as CEO. Przybyl, previously president and CEO of Akorn pharmaceuticals, will also join ANI's board of directors. Przybyl replaces Tom Anderson, ANI's founding CEO, who is leaving to pursue other opportunities.